We are at an interesting crossroads when it comes to pharma and digital health. Several years after the first iteration of digital patient solutions was initially launched, many pharma companies are taking a step back to strategically evaluate how they have performed in practice and the impact they have had on both patient and business outcomes.
Unfortunately, many platforms that pharma companies have either integrated within existing platforms or built have failed to meet those needs – for
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Abbott, American Diabetes Association Launches Therapeutic Nutrition Program for People with Diabetes
What You Should Know:
American Diabetes Association® (ADA) and Abbott announced a collaboration a new collaboration on a pilot therapeutic nutrition program to help people living with Type 2 diabetes.The collaboration aims to understand how diabetes technology like continuous glucose monitoring (CGM) systems can help people living with diabetes make informed decisions about their food and activity.
Abbott’s $2.6M Grant to Support Diabetes
Abbott is providing a $2.65 million grant
Read More
Oaktree Closes $2.3B Life Sciences Lending Fund
What You Should Know:
Oaktree Capital Management has closed its Life Sciences Lending Fund with a total capital commitment of $2.3B, representing the largest pool of capital ever raised dedicated to the space. Oaktree’s Life Sciences Lending Fund aims to generate attractive risk-adjusted returns by providing bespoke capital solutions to innovative companies across the life sciences sector globally, with a focus on high-growth subsectors, such as biopharma and medical
Read More
AWS Launches $100M Generative AI Center to Accelerate Healthcare, Life Sciences
What You Should Know:
Amazon Web Services, Inc. (AWS) announced an investment of $100M to launch the AWS Generative AI Innovation Center, with healthcare and life sciences as a prioritized industry (alongside Financial Services, Energy & Utilities, Telco, and others). The AWS Generative AI Innovation Center will connect AWS AI and machine learning (ML) experts with customers around the globe to help them envision, design, and launch new generative AI products, services, and
Read More
Feasibility of Cryoablation as a Treatment for Invasive Ductal Carcinoma
Millions of women worldwide are affected by breast cancer, a prevalent form of cancer. For approximately 8 out of 10 cases, invasive ductal carcinoma (IDC) is the most prevalent form of breast cancer. IDC is characterized by cancer cells that have spread beyond the milk ducts into the surrounding breast tissue.
While surgery, chemotherapy, and radiation therapy are commonly used to treat IDC, there is growing interest in alternative treatment options such as cryoablation provided by the ICE3
Read More
Walgreens and Freenome Partner to Increase Diversity in Research
What You Should Know:
Walgreens and Freenome form a multi-year relationship to advance clinical studies of Freenome’s blood-based tests for the early detection of cancer. Walgreens will combine its national footprint, patient insights, compliant recruitment technology and local infrastructure to engage diverse patient populations in Freenome’s multi-cancer research program. Walgreens will initially recruit patients across diverse populations for Freenome’s Sanderson Study, which aims to
Read More
Report: Inaccurate Drug Discount Requests Reach Nearly $1B
What You Should Know:
Kalderos, a data infrastructure and analytics company, identified nearly $1B in inaccurate drug discount requests from 2016-Q1 2023 on its drug discount management platform.The report, titled "Mission Critical: Bringing drug discount stakeholders together so patients win," outlines Kalderos' vision for a new paradigm of cooperation among drug discount program stakeholders in which everyone benefits — particularly patients.
Rising Costs of Inaccurate Drug
Read More
2023 Life Sciences Digital Pathology Adoption Survey Report
What You Should Know:
Nearly three-fourths of life sciences organizations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia®. Over half of these organizations (53%) still center their operations around legacy software systems primarily for basic image viewing despite growing adoption of artificial intelligence (AI) to accelerate the introduction of breakthrough therapeutics.The “2023
Read More
Simple HealthKit Launches At-Home Testing Kits on Walmart.com
What You Should Know:
Simple HealthKit, which provides the first human-centric, complete diagnostics platform with access to follow-up care for respiratory health, sexual health and chronic conditions partners with Walmart to make Simple HealthKit’s at-home HbA1c (Diabetes), Respiratory Wellness and Sexual Wellness Tests available at Walmart.com*.Simple HealthKit’s HbA1c (Diabetes) Tests identify key markers for Type 2 diabetes. Its Respiratory Wellness Tests identify Influenza A,
Read More
Range Biotechnologies Raises $5.2M to Advance Proteomics for Precision Health
What You Should Know:
Range Biotechnologies (Range Bio) announced $5.2M in seed funding, led by TechBio-focused ARTIS Ventures with participation from Pear VC, Page One Ventures, Civilization Ventures, Pillar, Four Cities Capital, Hawktail, and others. Proteomics, the study of proteins in the body, has the potential to improve human health in several ways. For example, proteomic studies can help identify which proteins correlate with a certain disease or drug response.
Read More
